kabutan

MEDIKIT CO.,LTD, July-September (2Q) Ordinary Profit Increases by 3%

Mon Nov 11, 2024 4:15 pm JST Earnings

7749 MEDIKIT CO.,LTD 【J-GAAP】

Earnings Report

MEDIKIT CO.,LTD <7749> [TSE-S] announced its financial results after the market closed on November 11th (16:15). The consolidated ordinary profit for the cumulative second quarter of the fiscal year ending March 2025 (April to September) decreased by 5.1% from the same period last year to 2.27 billion yen, resulting in a decrease in profits compared to the previous forecast of a 1.7% increase.

However, The progress rate against the 4.22 billion yen full-year plan was 53.9%, also surpassing the five-year average of 50.3%.

Based on the first-half performance announced by the company and the unchanged full-year plan, our calculation indicates that the consolidated ordinary profit for the October to March period (second half) is expected to decrease by 18.2% from the same period last year to 1.94 billion yen.

In the most recent three-month period, from July to September (2Q), the consolidated ordinary profit grew by 3.1% from the same period last year, reaching 1.17 billion yen. The operating profit margin rose from 19.8% in the same period last year to 20.2%.

Kabutan News

Actual Results

Accumulated Results 2nd Quarter
Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Progress Rate vs. First Half Announce Accounting Standards
Apr - Sep, 2022 10,562 2,024 2,061 1,196 71.3 49.3 Nov 11, 2022 J-GAAP
Apr - Sep, 2023 10,845 2,276 2,401 1,320 78.6 50.2 Nov 10, 2023 J-GAAP
Apr - Sep, 2024 11,285 2,220 2,279 1,278 86.4 53.9 Nov 11, 2024 J-GAAP
YoY +4.1% -2.5% -5.1% -3.2% +9.9%

First Half Results vs. Previous Guidance

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Apr - Sep, 2024 Guidance 11,365 2,402 2,442 1,392 94.0 45 May 15, 2024 J-GAAP
Apr - Sep, 2024 Results 11,285 2,220 2,279 1,278 86.4 45 Nov 11, 2024 J-GAAP
Revision Rate -0.7% -7.6% -6.7% -8.2% -8.1%

Current Period Guidance

Second Half Results

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Oct - Mar, 2023 11,005 2,401 2,380 1,749 107.1 45 May 15, 2024 J-GAAP
Oct - Mar, 2024 Guidance 11,100 1,942 1,947 1,467 100.4 45 Nov 11, 2024 J-GAAP
YoY +0.9% -19.1% -18.2% -16.1% -6.3%

Current Period Guidance

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Mar, 2023 21,607 4,118 4,177 2,864 170.7 100 May 15, 2023 J-GAAP
Mar, 2024 21,850 4,677 4,781 3,069 188.0 80 May 15, 2024 J-GAAP
Mar, 2025 Guidance 22,385 4,162 4,226 2,745 187.8 90 May 15, 2024 J-GAAP
YoY +2.4% -11.0% -11.6% -10.6% -0.1%

Quarterly Results

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Operating Profit Margin Announce Accounting Standards
Jul - Sep, 2023 5,296 1,046 1,137 756 45.0 19.8 Nov 10, 2023 J-GAAP
Oct - Dec, 2023 6,015 1,423 1,417 811 48.3 23.7 Feb 9, 2024 J-GAAP
Jan - Mar, 2024 4,990 978 963 938 57.4 19.6 May 15, 2024 J-GAAP
Apr - Jun, 2024 5,628 1,078 1,107 405 27.4 19.2 Aug 9, 2024 J-GAAP
Jul - Sep, 2024 5,657 1,142 1,172 873 59.0 20.2 Nov 11, 2024 J-GAAP
YoY +6.8% +9.2% +3.1% +15.5% +31.0%

Related Articles